During the past decade, Gita Rancane - cardiology private practice conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Gita Rancane - cardiology private practice" are "Atrial Fibrillation" (1 trials), "Heart Failure" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "Gita Rancane - cardiology private practice" in a lesser frequency.

Most popular intervention types in "Gita Rancane - cardiology private practice" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "Finerenone (BAY94-8862)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gita Rancane - cardiology private practice" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Gita Rancane - cardiology private practice". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Gita Rancane - cardiology private practice, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gita Rancane - cardiology private practice, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".